跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,140 条关于
“Bruton Tyrosine Kinase”
全部
5,140
临床试验
2,728
药物
562
机构
51
资讯
1,799
9年前
Ibrutinib Shows Promise in Treating Chronic Graft-Versus-Host Disease
2年前
Infection Risk With BTK Inhibitors Low, New CLL Study Finds
上个月
Acanthamoeba Encephalitis in Chronic Lymphocytic Leukemia: Case Report Highlights Infection Risk with Ibrutinib
9个月前
Novel BTK Degrader BGB-16673 Demonstrates 85% Response Rate in Heavily Pretreated CLL/SLL Patients
去年
Study Finds No Benefit in Pausing BTK Inhibitors During COVID-19 Vaccination for CLL Patients
去年
Fixed-Duration Venetoclax Regimen Reduces Long-Term Costs in CLL Treatment
去年
Novel Therapies Show Promise for Chronic Spontaneous Urticaria with Complete Response Rates Exceeding 30%
去年
Liso-cel Combined With Ibrutinib Shows Promise for Relapsed/Refractory CLL and Richter Transformation
2年前
Global CLL Trial Landscape Shows Robust Activity, Highlights Regional Disparities
3年前
Acalabrutinib, Obinutuzumab, and Venetoclax Triplet Shows Promise in High-Risk CLL
第 1 页,共 180 页
上一页
下一页